Australia's primary care sector is driven by small and medium-sized organisations: digital health ventures, condition-specific NFPs, allied health providers, GP practice groups, medtech companies and other health businesses outside government funding. Most have valuable offerings but can struggle to connect with buyers, not due to product issues.

The reason is access. And access in this market is not a marketing problem. It is a relationship problem.

Why the access problem is harder than it looks

The founders, executives and procurement decision-makers running health organisations in Australia are not hard to find. What they are is hard to reach through unsolicited commercial approaches that do not demonstrate immediate relevance to a specific problem they are currently trying to solve.

Research by Influitive found that 84% of B2B decision-makers start the buying process with a referral. That does not mean cold outreach never works. It means that outreach that arrives without context, credibility or a prior relationship starts at a significant disadvantage.

This is not a problem that better digital marketing solves. It is a problem that requires presence in the professional networks where those peer conversations happen. And building that presence from scratch in a sector with its own commissioning logic, regulatory environment, and professional community takes years.

A health SME trying to reach buyers in this market without that presence is starting from zero. Every approach lands in an inbox where it competes with every other vendor the buyer is ignoring. Every LinkedIn connection request signals intent before trust has been established. Every content piece produced without genuine sector knowledge reads as generic to a reader who knows the sector from the inside.

What a fractional BD operator brings that a hire or a campaign does not

A full-time BD hire at the level this market requires is expensive and hard to justify at an early stage. A junior contractor or digital marketing agency does not have the sector relationships or the domain knowledge to navigate health buyer behaviour. And a campaign, however well-designed, cannot substitute for a relationship built over time.

A seasoned fractional BD operator brings an established network, credibility with key opinion leaders and sector bodies, and sector-specific understanding of commissioning, evidence thresholds, and genuine door-openers, assets not quickly built or easily replicated.

TrustRadius (2026) found that only 23% of B2B buyers spoke with a vendor-provided reference before making a purchase. Most relied on peer conversations in their own networks. The fractional operator's value is not just what they know but who they know and the depth of those connections.

That is not a credential, but a commercial asset that takes a specific form in health: the ability to get a conversation started with a buyer who would not take a cold approach, to be the trusted referral rather than the unsolicited pitch, and to navigate the sector's internal logic in a way that builds rather than erodes credibility at every touchpoint.

The economics of fractional in this market

For health SMEs aiming to scale, the fractional model provides senior commercial expertise when the cost of a full-time role exceeds the revenue they can support. With AI handling infrastructure and process tasks, an experienced fractional operator can deliver what once took a team.

The same access challenge that complicates health BD makes experienced fractionals especially valuable. They already possess the network, sector knowledge, and credibility, eliminating the costly ramp-up and learning periods required for new hires.

For a health SME operator who is time-poor, risk-averse about external spend and already stretched across operational, financial and strategic responsibilities, that combination of existing network access, senior capability and fractional cost is the argument that matters. The question is not whether BD is necessary. The question is whether the resource you have deployed to do it can actually reach the buyers you need.

What good BD looks like in this market

The BD approach that works for health SMEs is not high volume. It is high quality and well-targeted. It builds presence in professional networks where peer conversations take place. It produces content that demonstrates a genuine understanding of the buyer's operating environment, specific enough to pass the attention filter of a time-poor founder who reads everything through the lens of whether it is relevant to their actual situation. And it develops relationships over time with the people whose recommendations carry weight when a buyer in their network starts asking who to call.

The buyers you need to reach are reachable. They go to the same events, read the same publications and trust the same peer networks. What determines whether they hear about you, and whether what they hear is worth acting on, is who is doing your BD and whether that person is already part of the world your buyers inhabit.

About the author

Kate Marie

Kate Marie is the founder of Medius Global and a business development and communications strategist with over 20 years of experience in Australian health. She has worked across primary care, digital health, medical education, NFPs and medtech, and consults to health organisations on go-to-market strategy, stakeholder engagement, content and fractional business development.

References

The content in this article is provided for general informational purposes only and does not constitute professional advice. See our full disclaimer.

Ready to assess your practice?

The free sale readiness tool shows exactly where your practice sits against buyer expectations.